These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34163622)

  • 1. A microscopic description of SARS-CoV-2 main protease inhibition with Michael acceptors. Strategies for improving inhibitor design.
    Ramos-Guzmán CA; Ruiz-Pernía JJ; Tuñón I
    Chem Sci; 2021 Jan; 12(10):3489-3496. PubMed ID: 34163622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiscale Simulations of SARS-CoV-2 3CL Protease Inhibition with Aldehyde Derivatives. Role of Protein and Inhibitor Conformational Changes in the Reaction Mechanism.
    Ramos-Guzmán CA; Ruiz-Pernía JJ; Tuñón I
    ACS Catal; 2021 Apr; 11(7):4157-4168. PubMed ID: 34192090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition Mechanism of SARS-CoV-2 Main Protease with Ketone-Based Inhibitors Unveiled by Multiscale Simulations: Insights for Improved Designs*.
    Ramos-Guzmán CA; Ruiz-Pernía JJ; Tuñón I
    Angew Chem Int Ed Engl; 2021 Dec; 60(49):25933-25941. PubMed ID: 34581471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Warhead Modulations on the Covalent Inhibition of SARS-CoV-2 M
    Martí S; Arafet K; Lodola A; Mulholland AJ; Świderek K; Moliner V
    ACS Catal; 2022 Jan; 12(1):698-708. PubMed ID: 35036042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of inhibition of SARS-CoV-2 M
    Arafet K; Serrano-Aparicio N; Lodola A; Mulholland AJ; González FV; Świderek K; Moliner V
    Chem Sci; 2020 Nov; 12(4):1433-1444. PubMed ID: 34163906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiscale Simulations of the Covalent Inhibition of the SARS-CoV-2 Main Protease: Four Compounds and Three Reaction Mechanisms.
    Grigorenko BL; Polyakov IV; Khrenova MG; Giudetti G; Faraji S; Krylov AI; Nemukhin AV
    J Am Chem Soc; 2023 Jun; 145(24):13204-13214. PubMed ID: 37294056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuning Proton Transfer Thermodynamics in SARS-CoV-2 Main Protease: Implications for Catalysis and Inhibitor Design.
    Zanetti-Polzi L; Smith MD; Chipot C; Gumbart JC; Lynch DL; Pavlova A; Smith JC; Daidone I
    J Phys Chem Lett; 2021 May; 12(17):4195-4202. PubMed ID: 33900080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atomistic-Level Description of the Covalent Inhibition of SARS-CoV-2 Papain-like Protease.
    Hognon C; Marazzi M; García-Iriepa C
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the non-covalent interaction between the PF-07321332 inhibitor and the SARS-CoV-2 main protease.
    Macchiagodena M; Pagliai M; Procacci P
    J Mol Graph Model; 2022 Jan; 110():108042. PubMed ID: 34653812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An insight into the interaction between α-ketoamide- based inhibitor and coronavirus main protease: A detailed in silico study.
    Banerjee S
    Biophys Chem; 2021 Feb; 269():106510. PubMed ID: 33285430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An integrated metabolomic and proteomic approach for the identification of covalent inhibitors of the main protease (M
    Baron G; Borella S; Della Vedova L; Vittorio S; Vistoli G; Carini M; Aldini G; Altomare A
    Talanta; 2023 Jan; 252():123824. PubMed ID: 36027618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catalytic Dyad Residues His41 and Cys145 Impact the Catalytic Activity and Overall Conformational Fold of the Main SARS-CoV-2 Protease 3-Chymotrypsin-Like Protease.
    Ferreira JC; Fadl S; Villanueva AJ; Rabeh WM
    Front Chem; 2021; 9():692168. PubMed ID: 34249864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitor binding influences the protonation states of histidines in SARS-CoV-2 main protease.
    Pavlova A; Lynch DL; Daidone I; Zanetti-Polzi L; Smith MD; Chipot C; Kneller DW; Kovalevsky A; Coates L; Golosov AA; Dickson CJ; Velez-Vega C; Duca JS; Vermaas JV; Pang YT; Acharya A; Parks JM; Smith JC; Gumbart JC
    Chem Sci; 2021 Jan; 12(4):1513-1527. PubMed ID: 35356437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitor binding influences the protonation states of histidines in SARS-CoV-2 main protease.
    Pavlova A; Lynch DL; Daidone I; Zanetti-Polzi L; Smith MD; Chipot C; Kneller DW; Kovalevsky A; Coates L; Golosov AA; Dickson CJ; Velez-Vega C; Duca JS; Vermaas JV; Pang YT; Acharya A; Parks JM; Smith JC; Gumbart JC
    bioRxiv; 2020 Sep; ():. PubMed ID: 32935106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Se-S Bond Formation in the Covalent Inhibition Mechanism of SARS-CoV-2 Main Protease by Ebselen-like Inhibitors: A Computational Study.
    Parise A; Romeo I; Russo N; Marino T
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Mechanism of Labelling Functional Cysteines by Heterocyclic Thiones.
    Mihalovits LM; Kollár L; Bajusz D; Knez D; Bozovičar K; Imre T; Ferenczy GG; Gobec S; Keserű GM
    Chemphyschem; 2024 Jan; 25(1):e202300596. PubMed ID: 37888491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QM/QM studies for Michael reaction in coronavirus main protease (3CL Pro).
    Taranto AG; Carvalho P; Avery MA
    J Mol Graph Model; 2008 Oct; 27(3):275-85. PubMed ID: 18567519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repurposing of FDA-approved drugs as potential inhibitors of the SARS-CoV-2 main protease: Molecular insights into improved therapeutic discovery.
    Ray AK; Sen Gupta PS; Panda SK; Biswal S; Bhattacharya U; Rana MK
    Comput Biol Med; 2022 Mar; 142():105183. PubMed ID: 34986429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Silico Drug Repositioning to Target the SARS-CoV-2 Main Protease as Covalent Inhibitors Employing a Combined Structure-Based Virtual Screening Strategy of Pharmacophore Models and Covalent Docking.
    Vázquez-Mendoza LH; Mendoza-Figueroa HL; García-Vázquez JB; Correa-Basurto J; García-Machorro J
    Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Covalent and non-covalent binding free energy calculations for peptidomimetic inhibitors of SARS-CoV-2 main protease.
    Awoonor-Williams E; Abu-Saleh AAA
    Phys Chem Chem Phys; 2021 Mar; 23(11):6746-6757. PubMed ID: 33711090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.